Sickle cell clinical trial now recruiting, Survey opens for those experiencing eye symptoms due to COVID-19
For more information on trials listed below, or to learn about other available opportunities to participate in research studies, call the NIH Clinical Center Office of Patient Recruitment 1- 866-444-2214, TTY: 800-877-8339. Or email prpl@cc.nih.gov. Se habla español. For those callers who are deaf, hard-of-hearing, blind, or speech impaired, the Federal Relay Service provides free telecommunications relay services.
Ocular Symptoms in Patients with Confirmed COVID-19 Infection: A Survey Study: Reports have shown that COVID-19 infection can be associated with eye symptoms. Through an online survey, researchers at the National Eye Institute (NEI) want to learn more about eye symptoms associated with COVID-19 infection. With this survey, investigators hope to discover how common eye symptoms are in COVID-19 infection and how they relate to other COVID-19 associated symptoms. The survey is expected to take 10 to 20 minutes. You do not need to have had any eye symptoms in order to participate. You may participate, if you are at least 18 years of age with a history of a confirmed positive COVID-19 test. Join by visiting: https://go.usa.gov/x7Tjh or email: eyecovid-19@nih.gov.
Researchers at the NHLBI are now recruiting patients with sickle cell disease to participate in a new clinical trial. This study will evaluate the effects of a natural supplement (Isoquercetin) on the markers reflecting blood clotting risks in patients with sickle cell disease. Refer to Study # 20-H-0137.
- Submitted by the NIH Clinical Center Office of Patient Recruitment